Bio-Path Holdings (BPTH)
(Delayed Data from NSDQ)
$1.10 USD
-0.09 (-7.56%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $1.00 -0.10 (-9.09%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/20/24 |
---|---|
Current Quarter | -1.02 |
EPS Last Quarter | -1.16 |
Last EPS Surprise | 24.68% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.20 |
Next Year | -4.04 |
EPS (TTM) | -40.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.02 | -1.01 | -6.20 | -4.04 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -1.02 | -1.01 | -6.20 | -4.04 |
High Estimate | -1.02 | -1.01 | -6.20 | -4.04 |
Low Estimate | -1.02 | -1.01 | -6.20 | -4.04 |
Year ago EPS | -6.40 | NA | -33.63 | -6.20 |
Year over Year Growth Est. | 84.06% | NA | 81.56% | 34.84% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.02 | -1.01 | -6.20 | -4.04 |
7 Days Ago | -1.02 | -1.01 | -6.20 | -4.04 |
30 Days Ago | -1.02 | -1.01 | -6.20 | -4.04 |
60 Days Ago | -0.93 | -0.93 | -5.53 | -3.65 |
90 Days Ago | -0.93 | -0.93 | -5.53 | -3.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.02 | -1.01 | -6.20 | -4.04 |
Zacks Consensus Estimate | -1.02 | -1.01 | -6.20 | -4.04 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.16 | -4.88 | NA | -6.40 | NA |
Estimate | -1.54 | -4.54 | NA | -6.80 | NA |
Difference | 0.38 | -0.34 | NA | 0.40 | 0.15 |
Surprise | 24.68% | -7.49% | NA | 5.88% | 7.69% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more